Catheter Precision details pro forma dilution to new investors at $1.25/share in ATM offering

Catheter Precision, Inc.

Historical net tangible book value as of Mar 31, 2025: $(15.8)M or $(1.71)/share; after offering: $(14.6)M or $(0.95)/share.
ATM offering assumes 4,333,333 shares at $0.30/share (May 14 close), net proceeds $1.2M; dilution to new investors $(1.25)/share.
Pro forma adjustments include 1,748,666 shares issued in April 2025; total outstanding after offering ~15.4M shares.
As of Mar 31, 2025, 17.4M warrants (weighted avg exercise $2.20) and 2.2M options outstanding represent additional dilution.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.